CoChat

Risk-Based Primary Prevention of Heart Failure: A Scientific Statement From the American Heart Association

Khan, Sadiya S., Breathett, Khadijah, Braun, Lynne T., Chow, Sheryl L., Gupta, Deepak K., Lekavich, Carolyn, Lloyd-Jones, Donald M., Ndumele, Chiadi E., Rodriguez, Carlos J., Allen, Larry A., on behalf of the American Heart Association Prevention Science Committee of the Council on Epidemiology and Prevention; Council on Cardiovascular and Stroke Nursing; Council on Basic Cardiovascular Sciences; Council on Clinical Cardiology; Council on Hypertension; and Council on Quality of Care and Outcomes Research · 2025 · Circulation

The DOI matches its Crossref record; 160 of the 160 references it cites were found in a registry or an index.

Abstract

The growing morbidity, mortality, and health care costs related to heart failure (HF) underscore the urgent need to prioritize its primary prevention. Whereas a risk-based approach for HF prevention remains in its infancy, several key opportunities exist to actualize this paradigm in clinical practice. First, the 2022 American Heart Association/American College of Cardiology/Heart Failure Society of America HF guidelines provided recommendations, for the first time, on the clinical utility of multivariable risk equations to estimate risk of incident HF. Second, the American Heart Association recently developed the PREVENT (Predicting Risk of Cardiovascular Disease Events) equations, which not only enable prediction of incident HF separately, but also include HF in the prediction of total cardiovascular disease. Third, the predominant phenotype of HF risk has emerged as the cardiovascular-kidney-metabolic syndrome. Fourth, the emergence of novel therapies that prevent incident HF (eg, sodium-glucose cotransporter-2 inhibitors) and target multiple cardiovascular-kidney-metabolic axes demonstrate growing potential for risk-based interventions. Whereas the concept of risk-based prevention has been established for decades, it has only been operationalized for atherosclerotic cardiovascular disease prevention to date. Translating these opportunities into a conceptual framework of risk-based primary prevention of HF requires implementation of PREVENT-HF (Predicting Risk of Cardiovascular Disease Events–Heart Failure) equations, targeted use of cardiac biomarkers (eg, natriuretic peptides) and echocardiography for risk reclassification and earlier detection of pre-HF, and definition of therapy-specific risk thresholds that incorporate net benefit and cost-effectiveness. This scientific statement reviews the current evidence for accurate risk prediction, defines strategies for equitable prevention, and proposes potential strategies for the successful implementation of risk-based primary prevention of HF.

Overview

Integrity signals

Registry

Crossref · 10.1161/cir.0000000000001307

Cites

160 of 160 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

5 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 160 references

Cited by

See all 94

Metadata

Authors
Khan, S. S., Breathett, K., Braun, L. T., Chow, S. L., Gupta, D. K., Lekavich, C., Lloyd-Jones, D. M., Ndumele, C. E., Rodriguez, C. J., Allen, L. A., & on behalf of the American Heart Association Prevention Science Committee of the Council on Epidemiology and Prevention; Council on Cardiovascular and Stroke Nursing; Council on Basic Cardiovascular Sciences; Council on Clinical Cardiology; Council on Hypertension; and Council on Quality of Care and Outcomes Research
Venue
Circulation
Published
2025-05-20
Volume
151
Issue
20
Pages
e1006-e1026
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W4409482288
Cited by
75
References
160
Citations by year
2026: 49 · 2025: 26
FWCI
13.63
Type
journal article
Language
en
Open access
closed
Locations
  • Circulation (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
Keywords
heart failure, primary prevention, risk-based prevention, risk prediction, PREVENT equations, cardiovascular-kidney-metabolic syndrome, SGLT2 inhibitors, natriuretic peptides, echocardiography, risk reclassification, net benefit, cost-effectiveness, risk thresholds
MeSH terms
Heart Disease Risk Factors, American Heart Association, Heart Failure, Humans, Primary Prevention, Risk Factors, United States, Risk Assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Risk-Based Primary Prevention of Heart Failure: A Scientific Statement From the American Heart Association. https://app.cochat.ai/papers/10.1161/cir.0000000000001307
The paper
Khan, S. S., Breathett, K., Braun, L. T., Chow, S. L., Gupta, D. K., Lekavich, C., Lloyd-Jones, D. M., Ndumele, C. E., Rodriguez, C. J., Allen, L. A., & on behalf of the American Heart Association Prevention Science Committee of the Council on Epidemiology and Prevention; Council on Cardiovascular and Stroke Nursing; Council on Basic Cardiovascular Sciences; Council on Clinical Cardiology; Council on Hypertension; and Council on Quality of Care and Outcomes Research. (2025). Risk-Based Primary Prevention of Heart Failure: A Scientific Statement From the American Heart Association. Circulation. https://doi.org/10.1161/cir.0000000000001307

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.